June 5, 2024
Molecular Devices is the world’s only company offering a service to manufacture standardized, quality-tested patient-derived organoids at a scale of many millions per batch SAN JOSE, Calif., and CARDIFF, Wales – Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK. The multi-million-pound facility was custom-built for the [...]
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
June 4, 2024
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody [...]
June 4, 2024
SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments. "We are excited to deliver for our NextSeq 1000/2000 customers improved sequencing with faster run times, [...]
Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation
June 4, 2024
INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its mission to reduce workflow times and grueling manual steps with the launch of its new Valita Aggregation Pure assay. The plate-based 96-well screening tool offers rapid, high-throughput protein aggregation detection and quantification, providing robust aggregation data in as little as [...]
June 4, 2024
This unprecedented approach integrates genomic, proteomic, and clonotypic assessment of subclonal multiple myeloma and its precursor stages Late-breaking data on clonal tracking in smoldering to active myeloma progression presented at the European Hematology Association (EHA) show on June 14 SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, [...]
Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research
June 4, 2024
Quebec City, Canada – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin [...]
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
June 4, 2024
Siren Biotechnology to receive products, technologies and contract testing services to develop gene therapy treatments for cancer Experts from MilliporeSigma’s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to 40-plus biotechnology companies since 2014 BURLINGTON, Mass. -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, [...]
Syngenta opens rights to genome-editing and breeding technologies to boost agricultural innovation
June 4, 2024
Providing rights to academic research globally aimed at enabling solutions to complex challenges and driving sustainability in food and agriculture Expanding the potential of CRISPR-based technologies through the collaborative innovation platform Shoots by Syngenta Syngenta Group, one of the world’s largest agricultural technology companies, will provide rights to selected genome-editing and breeding technologies for [...]
AmpleLogic Launches Advanced aPaaS for Life Sciences with 14 Ready-to-Use Applications
June 4, 2024
HYDERABAD, India -- AmpleLogic, a leading provider of GAMP solutions, announces the launch of its revolutionary Application Platform as a Service (aPaaS) designed specifically for the life sciences sector. This cutting-edge platform leverages low-code/no-code technology to accelerate digitization in life sciences industry while enhancing operational efficiency and ensuring compliance with regulatory standards from USFDA, MHRA, EMEA, ISO, and [...]
New Duplex-Specific Nuclease (DSN): Most Selective dsDNase
June 4, 2024
ZYMO RESEARCH UNVEILS PUREREC DSN: THE MOST SELECTIVE DUPLEX-SPECIFIC NUCLEASE IRVINE, Calif. — Zymo Research, a leader in biotechnological advancement has launched a new nuclease called PureRec Duplex-Specific Nuclease (DSN) that selectively digests double stranded DNA (dsDNA). This new PureRec DSN promises unparalleled specificity in targeting duplex DNA, unlocking a variety of potential applications. DSN selectively digests dsDNA [...]

